Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

S M. de la Monte - Current Alzheimer Research, 2012 - benthamdirect.com
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

Aberrant insulin signaling in Alzheimer's disease: current knowledge

G Bedse, F Di Domenico, G Serviddio… - Frontiers in …, 2015 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia affecting elderly people. AD
is a multifaceted pathology characterized by accumulation of extracellular neuritic plaques …

[PDF][PDF] State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease

EM Rhea, M Leclerc, HN Yassine… - Aging and …, 2024 - pmc.ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is common and increasing in prevalence worldwide, with
devastating public health consequences. While peripheral insulin resistance is a key feature …

Blood-based protein biomarkers for diagnosis of Alzheimer disease

JD Doecke, SM Laws, NG Faux, W Wilson… - Archives of …, 2012 - jamanetwork.com
Objective To identify plasma biomarkers for the diagnosis of Alzheimer disease (AD). Design
Baseline plasma screening of 151 multiplexed analytes combined with targeted biomarker …

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease

SM de la Monte - Drugs, 2012 - Springer
Alzheimer's disease (AD) is the most common cause of dementia in North America. Growing
evidence supports the concept that AD is fundamentally a metabolic disease that results in …

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?

F Bassil, PO Fernagut, E Bezard, WG Meissner - Progress in neurobiology, 2014 - Elsevier
Abstract Insulin and Insulin Growth Factor-1 (IGF-1) play a major role in body homeostasis
and glucose regulation. They also have paracrine/autocrine functions in the brain. The …

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy

AJ Westwood, A Beiser, C DeCarli, TB Harris… - Neurology, 2014 - AAN Enterprises
Objective: To relate serum insulin-like growth factor-1 (IGF-1) to risk of Alzheimer disease
(AD) dementia and to brain volumes in a dementia-free community sample spanning middle …

[HTML][HTML] Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture

E Cape, RJ Hall, BC van Munster, A de Vries… - Journal of …, 2014 - Elsevier
Objective Exaggerated central nervous system (CNS) inflammatory responses to peripheral
stressors may be implicated in delirium. This study hypothesised that the IL-1β family is …

Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains

MJ Quesnel, A Labonté, C Picard, H Zetterberg… - Brain, 2024 - academic.oup.com
Insulin, insulin-like growth factors (IGF) and their receptors are highly expressed in the adult
hippocampus. Thus, disturbances in the insulin-IGF signalling pathway may account for the …

Cellular Contributions to Glymphatic and Lymphatic Waste Clearance in the Brain

LCD Smyth, N Beschorner… - Cold Spring …, 2024 - cshperspectives.cshlp.org
Cerebrospinal fluid (CSF) bathes and cushions the brain; however, it also serves a major
role in the clearance of metabolic wastes and in the distribution of glucose, lipids, and amino …